Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | F2 | P00734 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.41 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.41 |
| ▸ | HTR3B | O95264 | 1/20 | 0.41 |
| ▸ | HTR3A | P46098 | 1/20 | 0.41 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.41 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.38 |
| ▸ | CHRNA5 | P30532 | 1/20 | 0.38 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4022532 | 0.84 | PLA2G7 (0.42) | TSHRLMNAF2KMT2AMEN1 | |
| SCHEMBL4022586 | 0.83 | TSHR (0.47) | TSHRLMNAF2KMT2AMEN1 | |
| SCHEMBL4023623 | 0.81 | KMT2A (0.42) | TSHRLMNAF2KMT2AMEN1 | |
| SCHEMBL4024104 | 0.76 | F2 (0.45) | TSHRLMNAF2KMT2AMEN1 | |
| SCHEMBL133554 | 0.75 | KMT2A (0.53) | TSHRLMNAF2KMT2AMAPT | |
| SCHEMBL19309377 | 0.75 | KMT2A (0.53) | TSHRLMNAF2KMT2AMAPT | |
| SCHEMBL4026508 | 0.75 | TSHR (0.40) | TSHRLMNAF2KMT2AMEN1 | |
| SCHEMBL1232166 | 0.73 | LMNA (0.50) | TSHRLMNAF2KMT2AMAPT | |
| SCHEMBL4026599 | 0.72 | F2 (0.45) | TSHRLMNAF2KMT2AMEN1 | |
| SCHEMBL4019343 | 0.72 | F2 (0.41) | TSHRLMNAF2KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7524986-B2 | Methods for producing aromatic carboxylic acids | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2009-04-28 | — | — | US | disclosed |
| US-20070191634-A1 | Methods for producing aromatic carboxylic acids | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2007-08-16 | — | — | US | disclosed |
| EP-1734029-A1 | PROCESS FOR PRODUCING AROMATIC CARBOXYLIC ACID | Daicel Chemical Industries, Ltd. (JP) | 2006-12-20 | — | — | EP | disclosed |
| US-7091342-B2 | Catalyst comprising cyclic acylurea compounds and processes for production organic compounds with the same | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2006-08-15 | — | — | US | disclosed |
| US-7034184-B2 | Process for producing azine compounds and oxime compounds | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2006-04-25 | — | — | US | disclosed |
| US-20050020439-A1 | Catalyst comprising cyclic acylurea compounds and processes for production organic compounds with the same | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2005-01-27 | — | — | US | disclosed |
| US-6768023-B2 | REACTING AN ESTER OR SALT OF NITROUS ACID WITH A COMPOUND THAT GENERATES A FREE RADICAL IN THE PRESENCE OF A NITROGEN CONTAINING CYCLIC COMPOUND CONTAINING AN N-OXY OR -HYDROXY IMIDE GROUP; FORMING OXIMES, NITRO COMPOUNDS, AND KETONES | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2004-07-27 | — | — | US | disclosed |
| US-20030204084-A1 | Process for producing azine compounds and oxime compounds | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2003-10-30 | — | — | US | disclosed |
| US-20030171618-A1 | Process for producing organic compounds using nitrites | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2003-09-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030204084-A1 | Process for producing azine compounds and oxime compounds | CBR1, DAO, ALKBH2 | TSHR 198/4885LMNA 3050/4885F2 1262/4885 |
| US-20030171618-A1 | Process for producing organic compounds using nitrites | NOS1, NOS2, NOS3 | TSHR 2997/4885LMNA 2540/4885F2 1189/4885 |
| US-20070191634-A1 | Methods for producing aromatic carboxylic acids | PAH, AHR, HAO2 | TSHR 2348/4885LMNA 3635/4885F2 515/4885 |
| US-20050020439-A1 | Catalyst comprising cyclic acylurea compounds and processes for production organic compounds with the same | MOGAT2, ACSS2, ACOX1 | TSHR 1846/4885LMNA 4215/4885F2 2558/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.